Vergelijking

Ganirelix vs. Histrelin

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

123246-29-7

220810-26-4

Molecuulmassa

1570.3 g/mol

1323.52 g/mol

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Ganirelix

Ganirelix competitively and reversibly binds the pituitary GnRH receptor, rapidly suppressing LH (and, less so, FSH) release — without the initial hormone 'flare' of GnRH agonists.

Histrelin

Continuous GnRH-agonist stimulation downregulates and desensitises the pituitary GnRH receptors — after the initial rise, LH, FSH and the sex hormones fall persistently.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Ganirelix	Histrelin
Duitsland	Op recept	Op recept
Verenigde Staten	Op recept	Op recept

Volledige vermeldingen

Ganirelix

Volledige vermelding →

Histrelin

Volledige vermelding →

Frequently asked questions

What is the difference between Ganirelix and Histrelin?: Ganirelix is classified as "Onderzoek (overig)", while Histrelin is classified as "Onderzoek (overig)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Ganirelix or Histrelin?: The highest available evidence level is "Humane RCT" for Ganirelix and "Humane RCT" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Ganirelix and Histrelin in Germany and the United States?: Duitsland: Ganirelix — Op recept, Histrelin — Op recept. Verenigde Staten: Ganirelix — Op recept, Histrelin — Op recept. These are factual summaries with source and review date on the individual pages.

Country

Ganirelix

Histrelin

Duitsland

Op recept

Verenigde Staten

Op recept

Frequently asked questions

What is the difference between Ganirelix and Histrelin?

Ganirelix is classified as "Onderzoek (overig)", while Histrelin is classified as "Onderzoek (overig)". Ganirelix: Ganirelix is a synthetic decapeptide and GnRH antagonist. In assisted reproduction (IVF) it prevents the premature LH surge during controlled ovarian stimulation. Histrelin: Histrelin is a nonapeptide GnRH agonist delivered as a once-yearly implant. Approved for central precocious puberty in children (Supprelin LA) and advanced prostate cancer (Vantas). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Ganirelix or Histrelin?

The highest available evidence level is "Humane RCT" for Ganirelix and "Humane RCT" for Histrelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Ganirelix and Histrelin in Germany and the United States?

Duitsland: Ganirelix — Op recept, Histrelin — Op recept. Verenigde Staten: Ganirelix — Op recept, Histrelin — Op recept. These are factual summaries with source and review date on the individual pages.